Merck

$84.94
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.78 (-2.05%) Today
$0.00 (0.00%) As of 4:55 PM EDT after-hours

Why Robinhood?

You can buy or sell Merck and other stocks, options, ETFs, and crypto commission-free!

About MRK

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. Read More The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species, which it sells to veterinarians, distributors, and animal producers. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The Alliances segment includes results from the Company's relationship with AstraZeneca LP related to sales of Nexium and Prilosec. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Employees
69,000
Headquarters
Kenilworth, New Jersey
Founded
1891
Market Cap
217.48B
Price-Earnings Ratio
23.79
Dividend Yield
2.60
Average Volume
7.96M
High Today
$86.93
Low Today
$84.49
Open Price
$86.30
Volume
9.82M
52 Week High
$87.25
52 Week Low
$66.10

Collections

MRK News

Reuters18h

Congo has given over 200,000 people Merck Ebola vaccine: government

20
CNBCAug 22

Three stocks to buy with the Fed split on rates, traders say

32,041
BenzingaAug 22

Analysts Share Stocks To Buy On Fed Uncertainty

14,845

MRK Earnings

$0.93
$1.05
$1.18
$1.30
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Available Oct 29, Pre-Market

Popular Stocks

More MRK News

Barron'sAug 16

Buy Merck Stock Because Its Immunotherapy Drug Is a Game-Changer, Analyst Says

674
MarketWatchAug 13

Dow jumps 69 points on gains for Apple Inc., Merck shares

193
ReutersAug 7

IN BRIEF: Merck says U.S. probing ties to electronic health record vendors

136
CNBCAug 5

Hide out in these three stocks as markets tank, investor says

1,959
ReutersJul 30

Edited Transcript of MRK earnings conference call or presentation 30-Jul-19 12:00pm GMT

80
ReutersJul 30

Cancer drug Keytruda, vaccines propel Merck to quarterly profit beat

350
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.